Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hikma Pharmaceuticals Plc. (HKMPF)

Hikma Pharmaceuticals Plc. (HKMPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hikma Pharmaceuticals Plc. 1 New Burlington Place London X0 W1S 2HR GBR

www.hikma.com P: 44-20-7399-2760

Description:

Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 4,917,714
Enterprise Value, $K 5,837,714
Shares Outstanding, K 220,229
Annual Sales, $ 2,875 M
Annual Net Income, $ 190,000 K
EBIT, $ 0 K
EBITDA, $ 608,000 K
60-Month Beta 0.50
% of Institutional Shareholders 0.00%
Float, K 220,229
% Float 100.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 8.19%
3-Year Return -0.76%
5-Year Return 0.00%
5-Year Revenue Growth 38.89%
5-Year Earnings Growth 60.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/23/24
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 0.72
Annual Dividend Yield 3.22%
Most Recent Dividend 0.470 on 03/21/24
Next Ex-Dividends Date 03/21/24
Dividend Payable Date 05/03/24
Dividend Payout Ratio 0.00%

HKMPF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 10.84
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 6.61%
Debt/Equity 0.51
Price/Sales 1.86
Price/Cash Flow 6.71
Price/Book 2.23
Book Value/Share 10.03
Interest Coverage 3.96

HKMPF Dividends

Date Value
03/21/24 $0.4700
08/10/23 $0.2500
03/23/23 $0.3700
08/18/22 $0.1900
03/17/22 $0.3600
03/18/21 $0.3400
08/20/20 $0.1600
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar